Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) rose 5.9% on Thursday . The company traded as high as $6.43 and last traded at $6.26. Approximately 293,158 shares traded hands during trading, a decline of 47% from the average daily volume of 551,962 shares. The stock had previously closed at $5.91.
Cybin Stock Down 4.5 %
The stock has a market cap of $845.52 million and a PE ratio of -23.71. The business’s fifty day moving average is $8.27 and its 200 day moving average is $9.17.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- How to Calculate Stock Profit
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Stock Average Calculator
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Use Stock Screeners to Find Stocks
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
